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Background. Despite microbiological cure, about 50% of tuberculosis (TB) patients have poor lung recovery. Neutrophils are 
associated with lung pathology; however, CD16/CD62L-defined subsets have not been studied in TB. Using flow cytometry, we 
monitored frequencies, phenotype, and function of neutrophils following stimulation with Mycobacterium tuberculosis (Mtb) whole 
cell lysate (WCL) and ESAT-6/CFP-10 fusion protein (EC) in relation to lung pathology.
Methods. Fresh blood from 42 adult, human immunodeficiency virus (HIV)–negative TB patients were analyzed pre- and post-
therapy, with disease severity determined using chest radiography and bacterial load. Flow cytometry was used to monitor fre-
quencies, phenotype, and function (generation of reactive oxygen species [ROS], together with CD11b, tumor necrosis factor, and 
interleukin 10 [IL-10] expression) of neutrophils following 2-hour stimulation with Mtb-specific antigens.
Results. Total neutrophils decreased by post-treatment compared to baseline (P = .0059); however, CD16brCD62Lbr (segmented) 
neutrophils increased (P = .0031) and CD16dimCD62Lbr (banded) neutrophils decreased (P = .038). Banded neutrophils were lower 
in patients with severe lung damage at baseline (P = .035). Following WCL stimulation, ROS from segmented neutrophils was higher 
in patients with low Mtb loads even after adjusting for sex (P = .038), whereas IL-10–expressing CD16dimCD62Llo cells were higher 
in patients with mild damage (P = .0397) at baseline. 
Conclusions. High ROS generation, low levels of banded neutrophils, and high levels of IL-10–expressing CD16dimCD62Llo neu-
trophils are associated with reduced lung pathology at diagnosis. Hence, neutrophils are potential early indicators of TB severity and 
promising targets for TB host-directed therapy.
Keywords.  tuberculosis; neutrophils; immunosuppression; inflammation; lung damage.
Mycobacterium tuberculosis (Mtb) causes tuberculosis (TB) 
which, despite being curable, is the single deadliest infectious 
disease known to humans, with about 10 million cases in 2019 
and 1.4 million deaths [1]. While there is an 85% treatment suc-
cess rate in human immunodeficiency virus (HIV)–negative 
patients, about 50% of treated individuals suffer from any type 
of post-TB lung disease, irrespective of smoking habits [2–4].
Patients with severe lung damage at diagnosis are more likely 
to experience lasting pulmonary disability [5, 6], suggesting 
that early diagnosis and treatment initiation are important 
in limiting residual impairment. It is likely that exacerbated 
inflammatory response against Mtb prior to diagnosis results 
in more severe lung pathology [7]. Hence, understanding the 
heterogeneity from host–Mtb interactions and infectious out-
comes [8] is crucial to improving treatment outcomes. This 
may be possible by reducing tissue damage and enhancing Mtb 
clearance with host-directed therapies [9, 10].
Neutrophils are a heterogeneous population whose com-
bined activity results in different extent of inflammation and 
disease outcomes [11–17]. Pillay and colleagues [18] ascribed 
CD16brCD62Lbr, CD16dimCD62Lbr, and CD16brCD62Llow neu-
trophils to segmented, banded, and hypersegmented subsets, 
respectively. Recently, Tak and collaborators [19] showed that 
neutrophils exhibiting low CD62L expression are distinct from 
segmented and banded subsets. Indeed, segmented neutrophils 
are the only phenotype circulating in homeostatic conditions 
and hypersegmented neutrophils suppress T-cell activation 
[18]; meanwhile, banded neutrophils exhibit efficient migration 
[20], exhibit superior bacterial containment in acute inflam-
mation [13], and are more abundant in patients who develop 
infectious complications [21]. Moreover, the percentage and ab-
solute number of banded neutrophils correlate positively with 
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Neutrophils are reactive to a wide range of stimuli, especially 
pathogen-associated molecular patterns (PAMPs) and damage-
associated molecular patterns (DAMPs) [24], and exposure 
to these enhances inflammatory and antibacterial responses 
and cell recruitment [25]. Kroon and collaborators [26] have 
revealed that increased neutrophil numbers are linked to ex-
cessive inflammation and severe Active TB (ATB) pathology. 
However, neutrophil numbers alone do not account for dif-
ferences in disease severity observed in patients at diagnosis. 
Hence, the frequencies, levels of activation, and functionality of 
different neutrophil phenotypes may be determinant factors of 
ATB severity.
Studies on the influence of different neutrophil subsets on 
specific inflammatory pathologies are scarce. CD16 and CD62L 
expression appear to provide a common ground for neutrophil 
identification, reconciling neutrophil granularity, density, and 
expression of key activation markers. Furthermore, functional 
attributes of different neutrophil subsets (based on CD16 and 
CD62L expression) have not been studied in TB to date. We 
hypothesize that variable frequencies and functionality of these 
subsets may explain the different levels of lung damage seen 
in ATB patients at baseline, and lung recovery after therapy. 
Thus, the aim of this study was to determine the dynamics of 
these neutrophil subsets at presentation and through standard 
treatment and to correlate these with severity of lung pa-
thology based on chest radiograph (CXR) scores and Mtb load 
(GeneXpert cycle threshold [Ct] value).
MATERIALS AND METHODS
Participants
A full scope of the methods used are provided in the 
Supplementary Data. Ethical approval was obtained from the 
Medical Research Council/The Gambia government joint 
ethics committee (SCC1523). Adult, HIV-negative TB pa-
tients with GeneXpert Ultra (Cepheid)–positive results were 
recruited from the TB clinic at the Medical Research Council 
Unit The Gambia at the London School of Hygiene and Tropical 
Medicine between April 2018 and October 2019 as part of a 
parent study, TB Sequel [27], after providing written informed 
consent. Sputum liquid mycobacterial growth indicator tube 
culture was performed at baseline, 2  months, and 6  months 
after TB treatment initiation, and blood samples were col-
lected at all time points. All patients were culture negative by 
6 months. CXRs were scored using the Ralph score (RS) [28] 
and patients were classified into mild and severe lung damage 
groups. Ct values were determined from the GeneXpert read-
ings at baseline and patients were classified into high and low 
Mtb load groups. Meanwhile, lung recovery was based on the 
ratio of RS at baseline to RS at 6 months for patients with ini-
tially severe lung damage, and the patients were classified into 
good and poor lung recovery groups.
Whole Blood Processing and Stimulation
Venous blood was collected in sodium heparin vacutainer tubes 
(Becton Dickinson). Full blood counts were performed using a 
Medonic M-series cell counter (Boule Medical AB, Sweden) and 
antigen stimulation was performed within 2 hours of collection. 
Two hundred microliters of whole blood was either left un-
stimulated (Nil) or stimulated with ESAT-6/CFP-10 (EC) fusion 
protein, H37Rv whole cell lysate (WCL), or phorbol 12-myris-
tate 13-acetate (PMA). Absolute granulocyte counts were also 
obtained from whole blood prior to stimulation. Details on the 
methodology are provided in the Supplementary Data.
Statistical Analysis
For cytokine responses, background was subtracted using 
the unstimulated (Nil) samples. Differences between base-
line, month 2, and month 6 samples within each group were 
analyzed using a Kruskal-Wallis test followed by Dunn mul-
tiple comparisons test as indicated [29]. Differences between 
paired baseline and month 6 samples were analyzed using a 
Wilcoxon matched-paired rank test. For comparisons between 
lung pathology groups, a Wilcoxon rank-sum test was used. 
The Benjamini-Hochberg test was used to adjust for multiple 
comparisons. A P value < .05 was considered to be statistically 
significant. All statistical analyses were performed using R soft-
ware version 3.5.2 [30].
RESULTS
Patient Demographics
Details about patient demographics are provided in the 
Supplementary Data. A  total of 42 HIV-negative adults with 
pulmonary TB were recruited, of whom 71% were males 
(Supplementary Table 1). The median CXR score at baseline 
was 57.5 (interquartile range [IQR], 25–65) with 21 patients 
in each of the groups: mild (RS <57.5), of which 38.1% had 1 
or more cavities, and severe (RS ≥57.5), of which 85.71% had 
cavities. For patients with severe damage at baseline, the me-
dian change in CXR score (∆RS) from baseline to 6  months 
was 6.5 (IQR, 1.59–16.5) with 7 patients in the good re-
covery group (∆RS ≥6.5) and 4 in the poor recovery group 
(∆RS <6.5). The median CXR scores for the mild and severe 
groups posttreatment (6  months) were 5 (IQR, 0–10) and 5 
(IQR, 5–13.5), respectively. For bacterial load calculations, 
we analyzed the GeneXpert Ct values for all participants. The 
median Ct value was 17.6 (IQR, 17.1–18.7) with 20 patients 
in the high bacterial load group (Ct <17.6) and 21 patients in 
the low bacterial load group (Ct >17.6). We found no corre-
lation between CXR-derived RS and GeneXpert MTB/RIF Ct 
(R = –0.23, P = .15) at baseline (data not shown). There was 
no difference in age between the severity groups in any cate-
gory (Supplementary Table 1). However, there was a significant 
association between sex and lung damage (P = .0006) and be-
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Changes in Neutrophil Frequencies Upon ATB Treatment Reveal Phenotype 
Heterogeneity
Neutrophil frequencies were determined using a hemoanalyzer, 
while granulocyte frequencies were obtained by computing the 
percentage of the granulocyte population from all single cells 
acquired by flow cytometry (Supplementary Figure 1D). The 
median granulocyte frequencies were 73.9 (IQR, 64.8–78.7) and 
59.4 (IQR, 55.2–71.4) at baseline and 48.4 (IQR, 41.7–57.8) and 
40.4 (IQR, 30.9–47.4) at 6 months for blood counts and flow 
cytometry, respectively. Total neutrophil frequencies (using full 
blood counts: P = .0059) and granulocyte frequencies (using 
flow cytometry: P = .00004) in unstimulated samples decreased 
significantly after treatment (Figure 1A and 1B).
Interestingly, while total neutrophil frequencies decreased, 
this was subset specific: Frequencies of banded neutrophils de-
creased whereas segmented neutrophils increased by 6 months 
of treatment (P = .038 and P = .0031, respectively; Figure 1C 
and 1D). There were no significant differences in frequencies of 
hypersegmented and CD16dimCD62Llo subsets (Figure 1E and 
1F). Patients with good lung recovery following treatment had 
significantly higher granulocyte frequencies following both EC 
(P = .011) and WCL (P = .042) stimulation than patients with 
poor lung recovery (Figure 1G).
Banded and Segmented Neutrophil Levels Correlate With Baseline Lung 
Pathology
At baseline and in the absence of stimulation, the frequencies 
of banded neutrophils were significantly lower (P = .0395), 
whereas segmented frequencies were higher but not significant 
(P = .0721) in patients with severe damage compared to those 
with mild damage (Figure 2A). Unadjusted and adjusted logistic 
regression modeling of the effect of neutrophil phenotypes on 
Figure 1. Longitudinal measurement of percentage blood neutrophil during antituberculosis treatment. A, Boxplots show median (horizontal line in box) and interquartile 
range of frequencies of granulocytes before and at treatment completion. The neutrophil counts in active TB patients were measured at baseline and at treatment completion 
(month 6). Neutrophil frequencies decreased upon treatment completion compared to baseline (n = 42). B, Similarly, granulocyte frequencies determined by flow cytometry 
also decreased after treatment. Immunofluorescence staining following 2-hour stimulation (or unstimulated [Nil]) with ESAT-6/CFP-10 fusion protein (EC), whole cell lysate 
(WCL), or phorbol 12-myristate 13-acetate (PMA) allowed for subset identification based on CD16 and CD62L expression levels. C and D, Segmented neutrophils decreased 
(C) and banded neutrophils increased (D) as homeostatic conditions were restored in the mild (not severe) group. E and F, CD16dimCD62Llo (E) and hypersegmented neutrophil 
frequencies (F) were unchanged between baseline and treatment completion. Each dot represents 1 individual patient. P values were obtained using the Wilcoxon signed-
rank test. G, Boxplots show frequencies of granulocytes at baseline in good (n = 7) and poor (n = 4) recovery groups. The Wilcoxon signed-rank test was used to analyze 
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lung damage provided further evidence of lower banded neu-
trophil levels (P = .035) in the severe damage group than in the 
mild damage group (Supplementary Table 2). Conversely, there 
was no difference in neutrophil frequencies between patients 
with high vs low Mtb loads at baseline (data not shown). At the 
end of treatment, we found no differences in proportions of 
neutrophil subsets between either the mild and severe damage 
or the low and high Mtb load groups (data not shown).
The decrease in granulocyte frequencies from baseline to month 
6 was more significant in patients with severe damage (P = .0029) 
or high Mtb load (P = .0098) compared to mild damage (P = .0161) 
or low Mtb load (P = .0186), respectively (Figure 2B and 
Supplementary Table 4), as confirmed by coefficients of x being 
further from the value 1 for both severe/high groups than mild/low 
groups (Supplementary Figure 2A and 2B). We also found that the 
decrease in banded and concomitant increase in segmented neu-
trophil frequencies from baseline to treatment completion (Figure 
1C and 1D) were exclusive to patients in the mild lung damage 
group (P = .0024 and XXX [ns], respectively) and low Mtb load 
group (P = .032 and P = .0098, respectively) (Figure 2C and 2D).
Figure 2. Percentage of neutrophils in severity groups before and after treatment. A, CD16/CD62L-defined neutrophil frequencies in active TB patients at baseline were 
analyzed by flow cytometry within Ralph score–defined mild (n = 21, O) and severe (n = 21, ∆) lung disease groups. Banded (CD16dimCD62Lbr) and segmented (CD16brCD62Lbr) 
neutrophils were lower and higher, respectively, in the severe group compared to the mild group. Values 2 standard deviations above/below the mean cell count were con-
sidered outliers and excluded from analysis. Data are presented as boxplots and analyzed using Wilcoxon rank-sum test. B, Granulocyte frequencies decreased with treat-
ment completion. This decrease was more significant in the severe damage and high Mycobacterium tuberculosis (Mtb) load groups compared to the mild damage and low 
Mtb load groups, respectively. C, Compared to baseline, banded neutrophils decreased significantly after treatment in the mild damage (n = 12) and low Mtb load (n = 11) 
groups, but not in the severe damage (n = 11) and high Mtb load groups (n = 11). D, In contrast, segmented neutrophils increased after treatment compared to baseline in 
the mild damage and low Mtb load groups but not in the severe damage and high Mtb load groups. Wilcoxon signed-rank test was used to analyze differences between 
treatment time within groups. Each dot represents a single patient. *P < .05; **P < .01. Abbreviations: 6M, month 6; BL, baseline; Ct, cycle threshold; ns, not significant; RS, 
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Treatment Leads to Changes in CD11b Expression by Neutrophil Subsets 
at Baseline
We monitored activation of the different neutrophil subsets 
by determining CD11b expression before and after treat-
ment. Generally, following Mtb-specific stimulation, 
CD11b+CD16dimCD62Llo neutrophil frequencies decreased 
after treatment. This trend in CD11b+CD16dimCD62Llo fre-
quency was significant in patients with severe damage (P = .011 
and P = .0059; with EC and WCL, respectively) and low 
Mtb load (P = .019 and ns; with EC and WCL, respectively) 
(Figure 3A). Also, WCL stimulation led to significant increase 
in CD11b+ banded neutrophil frequencies from baseline to 
treatment completion in patients with high Mtb loads (P = .014; 
Figure 3B).
Patients With Low Mtb Load at Baseline Have Higher Neutrophil 
Oxidative Indices
While changes in the frequency of specific neutrophil 
subsets following treatment appeared to be exclusive to in-
dividuals with mild lung damage at diagnosis, we also found 
that reactive oxygen species (ROS) generation at diagnosis 
was associated with differences in bacterial load but not 
lung damage. ROS generation is measured as previously de-
scribed [31, 32], using the neutrophil oxidative index (NOI), 
Figure 3. CD11b expression by neutrophils before and after treatment. A, Patients with severe lung damage (top panel, n = 11) or high Mycobacterium tuberculosis (Mtb) 
load (n = 11, middle panel) showed higher frequencies of CD11b+CD16dimCD62Llo neutrophils upon 2-hour stimulation with Mtb-specific antigens (ESAT-6/CFP-10 fusion 
protein and whole cell lysate [WCL]) at baseline compared to treatment completion; meanwhile, patients with mild lung damage (n = 12) and low Mtb load (n = 11) showed 
no significant difference in the frequency of this phenotype with treatment time. B, Patients with high Mtb load (n = 11) showed significant difference in the frequency of 
CD11b-expressing banded neutrophils (CD11b+CD16dimCD62Lbr) with WCL stimulation following treatment compared to baseline; the low Mtb load group (n = 11) showed 
none. Wilcoxon signed-rank test was used to analyze differences between treatment time within groups. *P < .05; **P < .01. Abbreviations: 6M, month 6; BL, baseline; EC, 
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which is the ratio of the median fluorescence intensity of 
DHR in stimulated samples (EC, WCL, or PMA) to that 
of unstimulated controls (Nil). CD16dimCD62Llo neutro-
phils displayed the highest NOI, yielding on average more 
ROS than banded (P = .0017), segmented (P = .0172), or 
hypersegmented (ns) neutrophils following WCL stimula-
tion at baseline (Figure 4A). The levels of WCL-stimulated 
ROS generated posttreatment between these subsets were 
similar (Figure 4B). Furthermore, NOIs of granulocytes, 
segmented, banded, and hypersegmented neutrophil pheno-
types correlated negatively with Mtb load following Mtb-
specific stimulations at diagnosis. These correlations were 
only significant upon WCL stimulation in total granulo-
cytes (R = 0.42, P = .0062; Figure 4C), banded neutrophils 
(R = 0.58, P < .0001; Figure 4D), and segmented neutrophils 
(R = 0.39, P = .0098; Figure 4E). Granulocytes, banded neu-
trophils, and segmented neutrophils generated relatively 
higher levels of ROS (P = .0044, P = .0007, and P = .0222, re-
spectively) upon WCL stimulation in patients with low com-
pared to high Mtb loads at baseline (Figure 5A). Moreover, 
sex-adjusted logistic regression modeling supported higher 
NOI (P = .038) in the low Mtb load group compared with 
the high Mtb load group only for segmented neutrophils 
(Supplementary Table 3). Meanwhile, there was no differ-
ence in NOI by any subset between the mild and severe lung 
damage groups at baseline (Figure 5B).
Interleukin 10+ Neutrophil Frequencies Vary With ATB Severity and 
Treatment
Overall, neutrophils portrayed monofunctional cytokine ex-
pression profiles and we observed higher levels of interleukin 
10 (IL-10) and tumor necrosis factor (TNF) production from 
CD16dimCD62Llo neutrophils following EC and WCL stimu-
lation compared with unstimulated samples (Supplementary 
Figure 3). At baseline, the frequency of IL-10+CD16dimCD62Llo 
neutrophils were higher following WCL stimulation in patients 
with mild lung damage (P = .0397) compared to those with se-
vere damage; however, this was not significant after adjusting 
for sex (Supplementary Table 3). Meanwhile there was no dif-
ference in the frequency of TNF-expressing neutrophils be-
tween severity groups (Figure 6A). We also found that IL-10+ 
hypersegmented neutrophil frequencies were significantly 
Figure 4. Neutrophil oxidative indices (NOIs) of neutrophil subsets. A, Pretreatment: low CD62L-expressing subsets CD16dimCD62Llo (n = 42) and CD16brCD62Llo 
(hypersegmented neutrophils, n = 27) produced more reactive oxygen species (ROS) than CD16dimCD62Lbr (banded, n = 42) or CD16brCD62Lbr (segmented, n = 42) neutrophils 
at diagnosis following 2 hours of stimulation with whole cell lysate (WCL). B, After treatment, the WCL-stimulated neutrophil subsets had relatively similar ROS generation 
capacities. P values were obtained using the Kruskal-Wallis test with Dunn posttest comparison. *P < .05; **P < .01. C, Spearman rank correlation of NOI of total gran-
ulocytes with bacterial burden at baseline. There was a weak correlation of the NOI of WCL-stimulated granulocytes with Mycobacterium tuberculosis loads in active TB 
patients, which was not observed with ESAT-6/CFP-10 fusion protein or with phorbol 12-myristate 13-acetate. D and E, CD16dimCD62Lbr (banded, D) and CD16dimCD62Lbr 
(segmented, E) neutrophils showed a similar correlation (moderately and weakly, respectively) as granulocytes. Abbreviations: Ct, cycle threshold; EC, ESAT-6/CFP-10 fusion 
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higher (P = .00857; data not shown) in patients with low Mtb 
load compared to high Mtb load at the 6-month time point. 
Interestingly, we found that IL-10+ banded neutrophil frequen-
cies increased in patients with severe lung damage (P = .014), 
whereas IL-10+ segmented neutrophils decreased in patients 
with mild lung damage (P = .044) from baseline to treatment 
completion with WCL stimulation (Figure 6B and 6C, respec-
tively). We also found no differences in either IL-10+ or TNF+ 
neutrophil frequencies between severity groups at the 6-month 
time point (data not shown).
DISCUSSION
Our aim was to determine if variations in neutrophil-related 
immunological correlates could explain the difference in ATB 
lung pathology at baseline and after successful therapy. We 
show that blood neutrophils from ATB patients show different 
phenotypes and functionality when exposed to Mtb-specific 
antigens before and after therapy. Notably, most patients with 
severe lung pathology at baseline were males. Hence, for the re-
covery analysis, the majority of women were excluded.
Low banded (CD16dimCD62Lbr) and high segmented 
(CD16brCD62Lbr) neutrophil frequencies at diagnosis were as-
sociated with more severe lung pathology. A previous study re-
ported significantly higher levels of segmented neutrophils in 
patients with greater areas of affected lungs, which supports our 
findings [22]. Additionally, we found no differences in neutro-
phil levels between the high and low Mtb load groups, which is 
consistent with previous observations from Scott et  al, where 
Figure 5. Neutrophil oxidative indices (NOIs) of neutrophil subsets in cycle threshold value–defined severity groups at diagnosis. A, At baseline, granulocytes, 
CD16dimCD62Lbr neutrophils (banded), and CD16brCD62Lbr neutrophils (segmented) had higher NOIs following 2-hour whole cell lysate stimulation in patients with low 
Mycobacterium tuberculosis (Mtb) load (n = 20) compared to those with high Mtb load (n = 18). B, There were no significant differences in NOI between mild (n = 20) and 
severe (n = 21) lung damage groups at baseline. Wilcoxon rank-sum test was used to analyze differences between groups at baseline. *P < .05; **P < .01; ***P < .005. 
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mice depleted of neutrophils showed no differences in lung and 
spleen Mtb burden [33].
We also observed decreased frequencies in total neutro-
phils after treatment, which supports previous findings by 
Ndlovu and colleagues [34]. This decrease was more pro-
nounced in patients with severe lung damage or high Mtb 
load compared with those with mild damage or low Mtb load, 
respectively. Frequencies of banded neutrophils decreased 
while segmented neutrophil frequencies increased. These 
changes in segmented neutrophils (characteristic of home-
ostatic conditions) and banded neutrophils (which circu-
late following inflammation) [18] occurred only in patients 
with mild lung damage or low Mtb loads, suggesting that 
homeostatic conditions are restored in patients with mild but 
not severe pathology soon after standard treatment comple-
tion. This supports previous suggestions that functional pul-
monary impairment only begins to improve several months 
after the end of standard TB therapy [35, 36].
We also observed higher baseline granulocyte frequencies 
in patients with poor recovery than in those showing good re-
covery. This is the first time that such evidence is shown and 
supports the argument that heightened neutrophil levels con-
tribute to lung damage. It also suggests that exacerbated neutro-
phil levels in circulation reduce lung recovery potential.
The frequency of activated Mtb-specific 
CD11b+CD16dimCD62Llo neutrophils was reduced after 
Figure 6. Frequency of interleukin 10 (IL-10)+ neutrophils pretreatment following whole cell lysate (WCL) stimulation. A, Following 2-hour stimulation with WCL, the base-
line (BL) frequencies of IL-10–expressing CD16dimCD62Llo neutrophils were higher in patients with mild damage (n = 19) than in patients with severe damage (n = 20). There 
were no significant differences in tumor necrosis factor (TNF)–expressing neutrophil frequencies between ATB severity groups at diagnosis. Wilcoxon rank-sum test was 
used to analyze differences between groups at BL. B, Frequency of IL-10–expressing banded (IL-10+CD16dimCD62Lbr) neutrophils is higher at month 6 (6M) compared to BL in 
patients with severe lung damage. C, IL-10–expressing segmented (IL-10+CD16brCD62Lbr) neutrophil frequencies are higher at BL compared to 6M in the mild lung damage 
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treatment in patients with initially severe damage, suggesting 
that this subset may be preferentially activated pretreatment in 
ATB patients. While this supports previous findings that im-
proved Mtb control in mice is associated with reduced lung 
neutrophil accumulation within TB granulomas and decreased 
expression of CD11b on neutrophils [33], it also reveals a direct 
proinflammatory role played by CD16dimCD62Llo neutrophils in 
ATB pathogenesis, which is subsequently dampened following 
treatment and resolution of Mtb-induced lung inflammation/
pathology.
IL-10 is an immunomodulatory cytokine, usually associ-
ated with immunosuppressive outcomes in ATB [37]. At di-
agnosis, the proportion of IL-10–expressing CD16dimCD62Llo 
neutrophils were higher in patients with mild lung damage. 
To our knowledge, this is the first study to show circulating 
neutrophil–specific IL-10 expression during ATB disease in 
humans. Our results suggest that CD16dimCD62Llo neutro-
phils autoregulate their activated proinflammatory poten-
tial by expressing IL-10, which results in milder pathology. 
Hence, neutrophil-related IL-10–mediated immunosuppres-
sion may contribute to limiting ATB severity. Interestingly, 
our data reveal that levels of TNF-expressing neutrophils are 
similar between CXR or Mtb burden groups. This suggests an 
imbalance between neutrophilic pro- and anti-inflammatory 
cytokines, which results in immunosuppressive outcomes (in 
patients with mild pathology) mediated by CD16dimCD62Llo 
neutrophils pretreatment. Treatment completion resulted in 
increased and decreased IL-10 expression by banded (in pa-
tients with severe lung damage at baseline) and segmented (in 
patients with mild damage at baseline) neutrophils, respec-
tively, further highlighting the opposing ways in which these 
2 subtypes act.
While we found no differences in ROS generation levels 
between lung damage groups, NOIs of total, segmented, and 
banded neutrophils correlated positively with Ct values (ie, 
negatively with Mtb load) at baseline. To our knowledge, this 
is the first study that shows a relationship between neutrophilic 
ROS generation and Mtb load in ATB. This aligns with claims 
by others that reduced ROS is linked to increased susceptibility 
to bacterial and fungal infections in elderly individuals [38]. 
Furthermore, this correlation was only significant following 
WCL (not EC or PMA) stimulation. This is presumably because 
WCL contains more DAMPs and PAMPs, which neutrophils 
can recognize via pattern recognition receptors such as Toll-
like receptors or C-type lectin receptors [39, 40]. This is also 
the only instance where we see a similar functional outcome 
between segmented and banded neutrophil activities. It sug-
gests that ROS generation by neutrophils is a basic functional 
attribute, whereas cytokine expression in neutrophils may be 
more adaptable (leading to varied attributes in different pheno-
types or immune conditions). Hence, coupled to frequencies of 
neutrophil subsets and IL-10 expression levels, NOI could be 
useful as a biomarker for predicting the likelihood of developing 
severe ATB as well as for evaluating ATB severity at diagnosis.
In summary, we show that frequencies of segmented and 
banded neutrophil phenotypes and their capacity to generate 
ROS are linked to disease severity in HIV-negative ATB patients 
in The Gambia. Our data also show that increased ROS gener-
ation, high levels of banded neutrophils, and high frequencies 
of IL-10–expressing CD16dimCD62Llo all play a protective role 
in ATB pathogenesis by limiting lung impairment or reducing 
Mtb burden. Tuberculosis remains a global health threat, and 
we show that Mtb infection leads to neutrophil recruitment and 
differentiation into functional subsets. Our data suggest that 
while some neutrophil subsets are proinflammatory, others can 
be protective with immunosuppressive functions. Identifying 
the mechanism(s) that limit or promote neutrophil differenti-
ation into either subset can directly aid in the design of novel 
targeted therapeutics against Mtb. Thus, neutrophil-mediated 
(subtypes and their immunosuppressive or ROS generation 
capacities) TB susceptibility and disease severity can be targeted 
as immune and host-directed therapies for TB progression and 
severity based on the findings of this study.
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